Limin A. Liu

188 Shizi Street
Suzhou, 215006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Sirolimus plus roxadustat synergistically enhances immunosuppression and erythropoiesis in pure red cell aplasia: a multicenter trial.

Sirolimus plus roxadustat synergistically enhances immunosuppression and erythropoiesis in pure red cell aplasia: a multicenter trial.

Journal: Signal transduction and targeted therapy

Published: June 02, 2025

Securinine, a novel alkaloid, regulates cell cycle and EMT in gastric cancer by inducing iron-dependent cell death.

Securinine, a novel alkaloid, regulates cell cycle and EMT in gastric cancer by inducing iron-dependent cell death.

Journal: Frontiers in oncology

Published: April 29, 2025

Real-world Efficacy and Safety of Flumatinib as the First-line Treatment in Patients With de novo Philadelphia-positive Acute Lymphoblastic Leukemia.

Real-world Efficacy and Safety of Flumatinib as the First-line Treatment in Patients With de novo Philadelphia-positive Acute Lymphoblastic Leukemia.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 17, 2025

Enhanced B-1 self-renewal and attenuated atherosclerotic lesion development in Cd19cre/+Ldlr-/- mice on Western-type diet.

Enhanced B-1 self-renewal and attenuated atherosclerotic lesion development in Cd19cre/+Ldlr-/- mice on Western-type diet.

Journal: Atherosclerosis

Published: July 16, 2024

Combined emapalumab and ruxolitinib in patients with haemophagocytic Lymphohistiocytosis.

Combined emapalumab and ruxolitinib in patients with haemophagocytic Lymphohistiocytosis.

Journal: Blood cancer journal

Published: February 20, 2024

Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia.

Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia.

Journal: Blood cancer journal

Published: January 02, 2024

Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence.

Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence.

Journal: Annals of hematology

Published: December 14, 2023

First-line treatment of severe aplastic anemia: immunosuppressive therapy plus eltrombopag versus haploidentical hematopoietic stem cell transplantation, a multicenter prospective study.

First-line treatment of severe aplastic anemia: immunosuppressive therapy plus eltrombopag versus haploidentical hematopoietic stem cell transplantation, a multicenter prospective study.

Journal: Bone marrow transplantation

Published: October 22, 2023

Myelodysplastic syndrome associated-haemophagocytic lymphohistiocytosis: A retrospective study of 15 cases in a single centre.

Myelodysplastic syndrome associated-haemophagocytic lymphohistiocytosis: A retrospective study of 15 cases in a single centre.

Journal: British journal of haematology

Published: July 13, 2023

Specific Loss of ABCA1 (ATP-Binding Cassette Transporter A1) Suppresses TCR (T-Cell Receptor) Signaling and Provides Protection Against Atherosclerosis.

Specific Loss of ABCA1 (ATP-Binding Cassette Transporter A1) Suppresses TCR (T-Cell Receptor) Signaling and Provides Protection Against Atherosclerosis.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: October 17, 2022

Remission of universal vitiligo after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome.

Remission of universal vitiligo after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome.

Journal: Annals of hematology

Published: October 04, 2022

Severe aplastic anemia patients with infection who received an allogeneic hematopoietic stem cell transplantation had a better chance: Long-term outcomes of a multicenter study.

Severe aplastic anemia patients with infection who received an allogeneic hematopoietic stem cell transplantation had a better chance: Long-term outcomes of a multicenter study.

Journal: Frontiers in immunology

Published: May 28, 2022

Showing 1-12 of 47

Last Updated: 09/26/2026